Ventrus Biosciences (VTUS) IPO Prices at $6

December 17, 2010 9:39 AM EST Send to a Friend
Get Alerts VTUS Hot Sheet
Trade VTUS Now!
Join SI Premium – FREE
Ventrus Biosciences Inc. (Nasdaq: VTUS) prices its IPO of 2,900,000 shares at $6.00 per share, the low end of the expected $6-$7 range. The shares will open today on the Nasdaq Capital Market under the symbol "VTUS."

Rodman & Renshaw, LLC, and National Securities Corporation acted as co-lead managing underwriters for the offering.

Ventrus is a development stage specialty pharmaceutical company focused on the development of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoids, anal fissures and fecal incontinence.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

IPOs, Trader Talk

Related Entities

Rodman & Renshaw

Add Your Comment